RIPK1 and death receptor signaling drive biliary damage and early liver tumorigenesis in mice with chronic hepatobiliary injury

[1]  S. Henderson,et al.  TBK1 and IKKε prevent TNF-induced cell death by RIPK1 phosphorylation , 2018, Nature Cell Biology.

[2]  T. Luedde,et al.  Apoptosis and necroptosis in the liver: a matter of life and death , 2018, Nature Reviews Gastroenterology & Hepatology.

[3]  T. Luedde,et al.  Necroptosis microenvironment directs lineage commitment in liver cancer , 2018, Nature.

[4]  Ashley P Ng,et al.  RIPK1 prevents TRADD-driven, but TNFR1 independent, apoptosis during development , 2018, Cell Death & Differentiation.

[5]  Junying Yuan,et al.  TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in Aging , 2018, Cell.

[6]  M. Lopes,et al.  A Dual Role of Caspase-8 in Triggering and Sensing Proliferation-Associated DNA Damage, a Key Determinant of Liver Cancer Development , 2017, Cancer cell.

[7]  M. Pasparakis,et al.  Kinase-independent functions of RIPK1 regulate hepatocyte survival and liver carcinogenesis , 2017, The Journal of clinical investigation.

[8]  M. Bertrand,et al.  RIPK1 protects hepatocytes from Kupffer cells-mediated TNF-induced apoptosis in mouse models of PAMP-induced hepatitis. , 2017, Journal of hepatology.

[9]  Y. Shimizu,et al.  The Linear ubiquitin chain assembly complex acts as a liver tumor suppressor and inhibits hepatocyte apoptosis and hepatitis , 2017, Hepatology.

[10]  T. Luedde,et al.  RIPK1 Suppresses a TRAF2-Dependent Pathway to Liver Cancer. , 2017, Cancer cell.

[11]  N. Kaplowitz,et al.  Questions and controversies: the role of necroptosis in liver disease , 2016, Cell Death Discovery.

[12]  H. Ren,et al.  LUBAC deficiency perturbs TLR3 signaling to cause immunodeficiency and autoinflammation , 2016, The Journal of experimental medicine.

[13]  P. Vandenabeele,et al.  The pseudokinase MLKL mediates programmed hepatocellular necrosis independently of RIPK3 during hepatitis. , 2016, The Journal of clinical investigation.

[14]  M. Bertrand,et al.  RIPK1 protects from TNF-α-mediated liver damage during hepatitis , 2016, Cell Death & Disease.

[15]  Yong-mei Song,et al.  Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB , 2016, The Journal of Immunology.

[16]  T. Luedde,et al.  IκB kinaseα/β control biliary homeostasis and hepatocarcinogenesis in mice by phosphorylating the cell‐death mediator receptor‐interacting protein kinase 1 , 2016, Hepatology.

[17]  Junying Yuan,et al.  Activation of necroptosis in human and experimental cholestasis , 2016, Cell Death and Disease.

[18]  E. Esposito,et al.  NEMO regulates a cell death switch in TNF signaling by inhibiting recruitment of RIPK3 to the cell death-inducing complex II , 2016, Cell Death and Disease.

[19]  M. Bertrand,et al.  More to Life than NF-κB in TNFR1 Signaling. , 2016, Trends in immunology.

[20]  F. Chan,et al.  Necroptosis-independent signaling by the RIP kinases in inflammation , 2016, Cellular and Molecular Life Sciences.

[21]  N. Kaplowitz,et al.  Receptor interacting protein kinase 1 mediates murine acetaminophen toxicity independent of the necrosome and not through necroptosis , 2015, Hepatology.

[22]  P. Schirmacher,et al.  NEMO Prevents Steatohepatitis and Hepatocellular Carcinoma by Inhibiting RIPK1 Kinase Activity-Mediated Hepatocyte Apoptosis , 2015, Cancer cell.

[23]  M. Bertrand,et al.  NF-κB-Independent Role of IKKα/IKKβ in Preventing RIPK1 Kinase-Dependent Apoptotic and Necroptotic Cell Death during TNF Signaling. , 2015, Molecular cell.

[24]  Xu Guang Yan,et al.  RIP1 Kinase Is an Oncogenic Driver in Melanoma. , 2015, Cancer research.

[25]  P. Vandenabeele,et al.  Necroptosis and its role in inflammation , 2015, Nature.

[26]  J. Ninomiya-Tsuji,et al.  TAK1 control of cell death , 2014, Cell Death and Differentiation.

[27]  M. Pasparakis,et al.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis , 2014, Nature.

[28]  M. Pasparakis,et al.  Cutting Edge: RIPK1 Kinase Inactive Mice Are Viable and Protected from TNF-Induced Necroptosis In Vivo , 2014, The Journal of Immunology.

[29]  Mason R. Mackey,et al.  TAK1-mediated autophagy and fatty acid oxidation prevent hepatosteatosis and tumorigenesis. , 2014, The Journal of clinical investigation.

[30]  P. Schirmacher,et al.  Death receptor-independent FADD signalling triggers hepatitis and hepatocellular carcinoma in mice with liver parenchymal cell-specific NEMO knockout , 2014, Cell Death and Differentiation.

[31]  T. Luedde,et al.  A positive feedback loop between RIP3 and JNK controls non-alcoholic steatohepatitis , 2014, EMBO molecular medicine.

[32]  E. Seki,et al.  TAK1 regulates hepatic cell survival and carcinogenesis , 2014, Journal of Gastroenterology.

[33]  T. Luedde,et al.  RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation. , 2013, Cell reports.

[34]  P. Carmeliet,et al.  Safe TNF-based antitumor therapy following p55TNFR reduction in intestinal epithelium. , 2013, The Journal of clinical investigation.

[35]  Xiuli Liu,et al.  Absence of receptor interacting protein kinase 3 prevents ethanol‐induced liver injury , 2013, Hepatology.

[36]  E. Park,et al.  Transforming growth factor-β signaling in hepatocytes promotes hepatic fibrosis and carcinogenesis in mice with hepatocyte-specific deletion of TAK1. , 2013, Gastroenterology.

[37]  R. Wells,et al.  Robust cellular reprogramming occurs spontaneously during liver regeneration. , 2013, Genes & development.

[38]  G. Gores,et al.  Apoptosis and necrosis in the liver. , 2013, Comprehensive Physiology.

[39]  G. Kollias,et al.  Myeloid Takl Acts as a Negative Regulator of the LPS Response and Mediates Resistance to Endotoxemia , 2012, PloS one.

[40]  F. Tacke,et al.  Loss of caspase-8 protects mice against inflammation-related hepatocarcinogenesis but induces non-apoptotic liver injury. , 2011, Gastroenterology.

[41]  T. Tenev,et al.  The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. , 2011, Molecular cell.

[42]  S. Houser,et al.  Requirement of FADD, NEMO, and BAX/BAK for Aberrant Mitochondrial Function in Tumor Necrosis Factor Alpha-Induced Necrosis , 2011, Molecular and Cellular Biology.

[43]  A. Waisman,et al.  Oligodendrocyte-Specific FADD Deletion Protects Mice from Autoimmune-Mediated Demyelination , 2010, The Journal of Immunology.

[44]  Thomas J. Fuchs,et al.  TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. , 2010, Cancer cell.

[45]  J. Banales,et al.  Bicarbonate secretion of mouse cholangiocytes involves Na+‐HCO  3− cotransport in addition to Na+‐independent Cl−/HCO3− exchange , 2010, Hepatology.

[46]  S. Akira,et al.  Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis , 2009, Proceedings of the National Academy of Sciences.

[47]  Xiaodong Wang,et al.  TNF-α Induces Two Distinct Caspase-8 Activation Pathways , 2008, Cell.

[48]  G. Longton,et al.  TRAIL-R deficiency in mice enhances lymph node metastasis without affecting primary tumor development. , 2008, The Journal of clinical investigation.

[49]  T. Luedde,et al.  Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma , 2007 .

[50]  K. Rajewsky,et al.  T Cell–specific Ablation of Fas Leads to Fas Ligand–mediated Lymphocyte Depletion and Inflammatory Pulmonary Fibrosis , 2004, The Journal of experimental medicine.

[51]  V. Dixit,et al.  Kinase RIP3 Is Dispensable for Normal NF-κBs, Signaling by the B-Cell and T-Cell Receptors, Tumor Necrosis Factor Receptor 1, and Toll-Like Receptors 2 and 4 , 2004, Molecular and Cellular Biology.

[52]  Klaus Rajewsky,et al.  NEMO/IKKγ-Deficient Mice Model Incontinentia Pigmenti , 2000 .

[53]  C. Kellendonk,et al.  Hepatocyte‐specific expression of Cre recombinase , 2000, Genesis.

[54]  M. Pasparakis,et al.  RIP Kinases in Liver Cell Death, Inflammation and Cancer. , 2019, Trends in molecular medicine.

[55]  P. Meier,et al.  Checkpoints in TNF-Induced Cell Death: Implications in Inflammation and Cancer. , 2018, Trends in molecular medicine.

[56]  T. Luedde,et al.  Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma. , 2007, Cancer cell.

[57]  G. Courtois,et al.  NEMO/IKK gamma-deficient mice model incontinentia pigmenti. , 2000, Molecular cell.